H2 Receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program

Am J Respir Crit Care Med. 2018 Jun 15;197(12):1638-1641. doi: 10.1164/rccm.201801-0048LE.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Colorado
  • Female
  • Histamine H2 Antagonists / adverse effects*
  • Histamine H2 Antagonists / blood
  • Histamine H2 Antagonists / therapeutic use*
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / mortality*
  • Hypertension, Pulmonary / physiopathology
  • Male
  • Middle Aged
  • Risk Assessment
  • Veterans / statistics & numerical data*

Substances

  • Histamine H2 Antagonists